The trial, sponsored by the US Department of Veterans Affairs, addresses a significant unmet medical need for effective PTSD treatments among veterans, particularly in light of the limited efficacy of current pharmacological options. The study compares MBSR to Present Centered Group Therapy (PCGT), positioning MBSR as a potential complementary therapy in the mental health market. The findings could influence treatment guidelines and expand the market for non-pharmacological interventions in PTSD, potentially leading to partnerships with healthcare providers and mental health organizations. The trial's completion and results could enhance the credibility of MBSR, paving the way for broader adoption in clinical settings and potential reimbursement pathways.